• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to letter comments on: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).对关于以下内容的信件评论的回复：晚期胆管癌的分子靶向维持治疗与标准治疗的比较：一项国际、随机、对照、开放标签的III期伞式试验（SAFIR-ABC10-精准医学）
ESMO Open. 2025 Jul 18;10(8):105536. doi: 10.1016/j.esmoop.2025.105536.
2
Letter to the Editor Re: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomized, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).致编辑的信：关于晚期胆管癌的分子靶向维持治疗与标准治疗：一项国际、随机、对照、开放标签的III期伞式试验（SAFIR-ABC10-精准医学）
ESMO Open. 2025 Jul 15;10(8):105535. doi: 10.1016/j.esmoop.2025.105535.
3
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).晚期胆管癌的分子靶向维持治疗与标准治疗对比：一项国际、随机、对照、开放标签的III期伞形试验（SAFIR-ABC10-精准医学）
ESMO Open. 2025 Apr 9;10(5):104540. doi: 10.1016/j.esmoop.2025.104540.
4
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.多西环素预防美国细菌性性传播感染：DoxyPEP多中心、开放标签、随机对照试验及开放标签扩展研究的最终结果
Lancet Infect Dis. 2025 Mar 24. doi: 10.1016/S1473-3099(25)00085-4.
5
Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.子痫前期和子痫妇女的替代硫酸镁治疗方案。
Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD007388. doi: 10.1002/14651858.CD007388.pub3.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方：益处与风险
7
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial.阑尾切除术联合标准药物治疗与单纯标准药物治疗对溃疡性结肠炎缓解期维持的疗效比较（ACCURE）：一项实用、开放标签、国际性随机试验
Lancet Gastroenterol Hepatol. 2025 Jun;10(6):550-561. doi: 10.1016/S2468-1253(25)00026-3. Epub 2025 Apr 11.
8
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.基于吉西他滨的晚期胆管癌化疗
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD011746. doi: 10.1002/14651858.CD011746.pub2.
9
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.放疗或放射外科手术后脑放射性坏死的治疗干预措施。
Cochrane Database Syst Rev. 2018 Jul 9;7(7):CD011492. doi: 10.1002/14651858.CD011492.pub2.
10
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.硼替佐米、沙利度胺和地塞米松联合或不联合达雷妥尤单抗，随后进行达雷妥尤单抗维持或观察治疗，适用于适合移植的新诊断多发性骨髓瘤：CASSIOPEIA 随机对照 3 期试验的长期随访。
Lancet Oncol. 2024 Aug;25(8):1003-1014. doi: 10.1016/S1470-2045(24)00282-1. Epub 2024 Jun 15.

本文引用的文献

1
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).晚期胆管癌的分子靶向维持治疗与标准治疗对比：一项国际、随机、对照、开放标签的III期伞形试验（SAFIR-ABC10-精准医学）
ESMO Open. 2025 Apr 9;10(5):104540. doi: 10.1016/j.esmoop.2025.104540.
2
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.晚期 IDH1 突变型胆管癌患者ivosidenib 的最终总生存疗效结果：III 期随机临床 ClarIDHy 试验。
JAMA Oncol. 2021 Nov 1;7(11):1669-1677. doi: 10.1001/jamaoncol.2021.3836.
3
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.在治疗压力下，可操作转移性癌症基因组的有限进化。
Nat Med. 2021 Sep;27(9):1553-1563. doi: 10.1038/s41591-021-01448-w. Epub 2021 Aug 9.

Reply to letter comments on: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).

作者信息

Malka D, Borbath I, Lopes A, Vandamme T, Edeline J, Bridgewater J

机构信息

Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.

Department of Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

出版信息

ESMO Open. 2025 Jul 18;10(8):105536. doi: 10.1016/j.esmoop.2025.105536.

DOI:10.1016/j.esmoop.2025.105536
PMID:40682909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296461/
Abstract
摘要